The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Clinical trial NCT02013037 · COMPLETED

Trial details

NCT number: NCT02013037
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Antibody-mediated Rejection Hyperacute Rejection of Cardiac Transplant Left Ventricular Dysfunction Cardiac Allograft Vasculopathy Heart Graft Dysfunction

Start date: 2012-11-01
Primary completion: 2019-12-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.